Main indications for peroral anticoagulants: how to choose an optimal drug
Practical approaches to use of oral anticoagulants for prevention and treatment of thrombotic and thromboembolic complications in patients with atrial fibrillation, venous thromboembolism and coronary heart disease are considered. Comparison of main pharmacologic properties of DOACs and warfarin as...
Main Author: | I. S. Yavelov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2018-05-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/95 |
Similar Items
-
Elderly patient with atrial fibrillation and coronary risks
by: I. S. Yavelov
Published: (2021-07-01) -
Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation
by: IS Yavelov
Published: (2014-12-01) -
Антитромботическая терапия при фибрилляции предсердий: новые пероральные антикоагулянты
Published: (2014-12-01) -
NEW ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE
by: E. P. Panchenko
Published: (2015-12-01) -
Pulmonary embolism: inpatient and outpatient treatment
by: GE Gendlin, et al.
Published: (2014-12-01)